Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
15
|
pubmed:dateCreated |
1993-2-18
|
pubmed:abstractText |
The technical problem of neonatal diagnosis of haemoglobinopathies has definitely been solved. There is no longer a methodological obstacle to a formal distinction between heterozygous and homozygous subjects with sickle cell disease, despite the presence at birth of strong haemoglobin F and F-acetylated concentrations. In France as in the USA and Great Britain mass screening for sickle cell disease in the newborn is necessary because this disease is frequent- as a monogenic hereditary disease it ranks second to cystic fibrosis on average and first in the Paris region-detection is useful for an early diagnosis and the new method is inexpensive.
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
F
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0035-2640
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
42
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1893-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading | |
pubmed:year |
1992
|
pubmed:articleTitle |
[Neonatal diagnosis of hemoglobinopathies].
|
pubmed:affiliation |
Centre de la drépanocytose et des thalassémies, hôpital Henri-Mondor, Créteil.
|
pubmed:publicationType |
Journal Article,
English Abstract
|